pillbase.ru

ONCASPAR

Active substance: pegaspargase

INJECTION, SOLUTION · PEGASPARGASE 750 [iU]/mL

United StatesActive

Marketing holder: Servier Pharmaceuticals LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Oncaspar
    pegaspargase
    EMEA/H/C/003789
    Les Laboratoires Servier
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-e75d-7832-bd54-33bcab8370e8;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
72694-954
Registration status
Active
Dispensing
Prescription only
Route
INTRAMUSCULAR, INTRAVENOUS
Sources
  • product · openFDA NDC · 72694-954 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 72694-954 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 72694-954 · Verified 2026-10-09 · open in source